Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Beximco Pharma Share Price
  4. Beximco Pharma Share Regulatory News
  5. Restoration - Beximco Pharmaceuticals PLC

Pin to quick picksBeximco Pharma Regulatory News (BXP)

Beximco Pharma Information

Share Price Information for Beximco Pharma (BXP)

Share Price is delayed by 15 minutes
Get Live Data
50.00    7.50 (17.65%)
Bid:
45.00
Ask:
55.00
Spread: 10.00 (22.222%)
Market Cap: £223.06m
BXP Live PriceLast checked at - London Stock Exchange

Intraday Beximco Pharma Share Chart

Restoration - Beximco Pharmaceuticals PLC

Today 07:30

RNS Number : 9334J
AIM
26 June 2026
 

NOTICE

 

26/06/2026 7:30am

 

RESTORATION OF TRADING ON AIM

 

BEXIMCO PHARMACEUTICALS PLC

 

Trading on AIM for the under-mentioned securities was temporarily suspended. The suspension is lifted from 26/06/2026 7:30am, the annual audited accounts having been published.

 

GLOBAL DEPOSITARY RECEIPTS (EACH REPRESENTING 1 ORDINARY SHARE OF BDT10 EACH), FULLY PAID

(B0DM5S5) (US0885792061)

 

If you have any queries relating to the above, please contact the company's nominated adviser on +44 (0)20 3368 3551 / 3555.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
EXCFIFLRREIRFIR
1234567
Date   Source Headline
28th Jan 20217:00 amRNSHalf Year Results 2020-21
22nd Jan 20217:00 amRNSPayment of Cash Dividend
21st Jan 20219:34 amRNSProposed acquisition of stake in Sanofi Bangladesh
18th Jan 20217:00 amRNSBoard Changes
14th Jan 20219:00 amRNSUpdate on the supply of COVID-19 vaccine
11th Jan 20217:00 amRNSStock Dividend Issued
11th Jan 20217:00 amRNSConfirmation of Board Changes
21st Dec 20207:00 amRNSAGM Statement
2nd Dec 202011:01 amRNSBoard Changes
23rd Nov 20207:00 amRNSNotice of AGM
16th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
13th Nov 20207:00 amRNSResults for First Quarter Ended 30 September 2020
11th Nov 20207:00 amRNSResults for the year ended 30 June 2020
5th Nov 20204:40 pmRNSSecond Price Monitoring Extn
5th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20202:40 pmRNSMOU with SII and GOB for COVID-19 vaccine
29th Oct 20207:00 amRNSNotification of Preliminary Results and AGM
21st Sep 20207:00 amRNSBeximco Pharma receives eighth FDA approval
28th Aug 202011:06 amRNSSecond Price Monitoring Extn
28th Aug 202011:00 amRNSPrice Monitoring Extension
28th Aug 20208:31 amRNSBeximco and SII to cooperate on a COVID-19 vaccine
30th Jul 20207:00 amRNSBoard Change
23rd Jun 20207:00 amRNSQ3 Financial Results and Business Update
21st May 20207:00 amRNSWorld’s first generic remdesivir for COVID-19
4th May 20207:00 amRNSCOVID-19 Update
30th Mar 20207:00 amRNSBeximco donates PPE to healthcare professionals
24th Feb 20207:00 amRNSBeximco announces Commercial Agreement with Mylan
29th Jan 20207:00 amRNSHalf Year Results 2019-20
20th Jan 202011:06 amRNSPayment of Cash Dividend
23rd Dec 201910:46 amRNSAGM Statement
19th Nov 20198:57 amRNSAGM Notification
14th Nov 20197:00 amRNSResults for First Quarter Ended 30 September 2019
11th Nov 20197:00 amRNSResults for the 12 month period ended 30 June 2019
29th Oct 20197:00 amRNSNotification of Preliminary Results and AGM
8th Aug 20199:18 amRNSUpdate on Dividend and Tax legislation changes
30th Jul 20197:00 amRNSBeximco launches fifth product in the US market
18th Jul 20194:01 pmRNSDividend and Tax changes for Bangladesh companies
29th Apr 20197:00 amRNS3rd Quarter Results
24th Apr 20197:00 amRNSBeximco receives FDA approval for Cyproheptadine
20th Feb 20197:00 amRNSBeximco Pharma to Acquire Eight ANDAs from Sandoz
4th Feb 201911:32 amRNSAppointment of Broker
31st Jan 20197:00 amRNSHalf Year Results 2018-19
22nd Jan 20197:00 amRNSPayment of Cash Dividend
27th Dec 20187:00 amRNSAGM Statement
27th Dec 20187:00 amRNSEGM Statement
30th Nov 20187:00 amRNSEGM Notification
30th Nov 20187:00 amRNSAGM Notification
29th Nov 20188:30 amRNSBeximco Pharma wins at Scrip Awards 2018
14th Nov 20187:00 amRNSResults for First Quarter Ended 30 September 2018
7th Nov 20187:00 amRNSResults for the 12 month period ended 30 June 2018
1234567

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Trending
IMM
Immupharma
LSE
0.54%
SCLP
Scancell Holdings
LSE
-3.16%
ALRT
Defence Holdings
LSE
-4.10%
GGP
Greatland Resources
LSE
1.74%
KOD
Kodal Minerals
LSE
0.00%